LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,806 | 4,381 | 5,040 | 5,502 | 5,792 |
| TOTAL | $3,903 | $4,431 | $5,100 | $5,511 | $5,811 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,903 | $4,431 | $5,100 | $5,511 | $5,811 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 129 | 36 | 8 | 23 | 26 |
| Accrued Expenses | 101 | 219 | 247 | 234 | 171 |
| Other current liabilities | 13,806 | 9,417 | 15,270 | 2,372 | 6,677 |
| TOTAL | $14,036 | $9,672 | $15,525 | $2,629 | $6,874 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,560 | 5,336 | 5,133 | 0 | 0 |
| TOTAL | $5,560 | $5,336 | $5,133 | $N/A | $N/A |
| Total Liabilities | $19,596 | $15,008 | $20,658 | $2,629 | $6,874 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 271 | 247 | 111 | 16 | 11 |
| Common Shares | 5 | 4 | N/A | 6 | 3 |
| Retained earnings | -442,040 | -434,344 | -439,629 | -426,306 | -429,876 |
| Other shareholders' equity | 0 | 0 | 0 | 5,140 | 5,325 |
| TOTAL | $-15,693 | $-10,577 | $-15,558 | $2,882 | $-1,063 |
| Total Liabilities And Equity | $3,903 | $4,431 | $5,100 | $5,511 | $5,811 |